Browse All

Current Filters

CLEAR FILTER x

TITLE

Low Risk of Motor Complications in Early Parkinson’s Disease Patients Treated with Opicapone in the EPSILON Study: Effect of Levodopa Dose

Author:Ferreira, Joaquim   Rascol, Olivier   Stocchi, Fabrizio   Antonini, Angelo   Dias, Bruno   Rocha, Francisco   Ramos, Daniel   Banisadr, Ghazal   Brigas, Helena   Holenz, Joerg   Poewe, Werner   

Session Name:P3: Movement Disorders: Parkinson's Disease Management 1  

Topic:Movement Disorders  

Program Number:P3.010  

Author Institution:Universidade Lisboa, Torres Vedras, Portugal  University of Toulouse, University Hospital of Toulouse, INSERM, Clinical Investigation Center CIC1436, Toulouse, France  IRCCS San Raffaele Pisana, Rome, Italy  University of Padova, Italy  BIAL – Portela & Ca S.A., Portugal  BIAL – Portela & Ca S.A. , Portugal  Amneal Pharmaceuticals, Evanston, IL  BIAL – Portela & Ca S.A., CORONADO (S. Romão E S. Mamede, Portugal  BIAL – Portela & Ca S.A., Coronado, Portugal  Medical University of Innsbruck, Innsbruck, Austria  

Effect of Opicapone on Sleep-related Complaints and Non-motor Burden in Parkinson’s Patients: A Post-hoc Analysis of the OASIS Trial

Author:Gago, Miguel   Costa, Raquel   Brigas, Helena   Dias, Bruno   Banisadr, Ghazal   Holenz, Joerg   Ferreira, Joaquim J.   

Session Name:P3: Movement Disorders: Parkinson's Disease Management 1  

Topic:Movement Disorders  

Program Number:P3.012  

Author Institution:Hospital da Senhora da Oliveira, Guimarães, Guimarães, Portugal  BIAL – Portela & Ca S.A., Coronado (S. Romão e S. Mamede), Portugal  BIAL – Portela & Ca S.A., CORONADO (S. Romão E S. Mamede, Portugal  BIAL – Portela & Ca S.A., Portugal  Amneal Pharmaceuticals, Evanston, IL  BIAL – Portela & Ca S.A., Coronado, Portugal  Universidade Lisboa, CNS-Campus Neurológico, Lisboa, Portugal